Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

Goey, KKH; Sorbye, H; Glimelius, B; Adams, RA; Andre, T; Arnold, D; Berlin, JD; ... Koopman, M; + view all Goey, KKH; Sorbye, H; Glimelius, B; Adams, RA; Andre, T; Arnold, D; Berlin, JD; Bodoky, G; de Gramont, A; Diaz-Rubio, E; Eng, C; Falcone, A; Grothey, A; Heineman, V; Hochster, HS; Kaplan, RS; Kopetz, S; Labianca, R; Lieu, CH; Meropol, NJ; Price, TJ; Schilsky, RL; Schmoll, H-J; Shacham-Shmueli, E; Shi, Q; Sobrero, AF; Souglakos, J; van Cutsem, E; Zalcberg, J; van Oijen, MGH; Punt, CJA; Koopman, M; - view fewer (2018) Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group. European Journal of Cancer , 100 pp. 35-45. 10.1016/j.ejca.2018.05.010 .

https://ift.tt/2LqHGvv